Comparison of intra- and postoperative findings and complications (entire and matched cohorts)
| . | Overall . | Matched . | ||||
|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | CSFD (59) . | Non-CSFD (59) . | P-value . |
| Intraoperative findings | ||||||
| Procedure time, min | 111 (91-153) | 110 (93-148) | 0.504 | 109 (88-146) | 120 (99-159) | 0.197 |
| Intraoperative blood loss, ml | 170 (70-460) | 50 (10-175) | 0.012 | 170 (50-420) | 100 (10-325) | 0.139 |
| Postoperative complications | ||||||
| Stroke | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Pneumonia | 0 | 5 (4.1%) | 0.070 | 0 | 4 (6.8%) | 0.042 |
| Continuous haemodiafiltration | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Gastrointestinal disorders | 1 (1.1%) | 2 (1.6%) | 0.717 | 1 (1.7%) | 1 (1.7%) | 1.000 |
| Access route injury | 3 (3.4%) | 3 (2.5%) | 0.749 | 3 (5.1%) | 3 (5.1%) | 1.000 |
| Wound problems | 2 (2.2%) | 1 (0.8%) | 0.418 | 0 | 0 | – |
| Infectious diseases | 1 (1.1%) | 1 (0.8%) | 0.855 | 1 (1.7%) | 1 (1.8%) | 1.000 |
| CSFD-related findings | ||||||
| SCI | 8 (9.0%) | 6 (4.9%) | 0.403 | 3 (5.1%) | 4 (7.3%) | 0.697 |
| Transient paraparesis | 6 (6.7%) | 3 (2.5%) | 0.182 | 3 (5.1%) | 2 (3.4%) | 0.648 |
| Permanent paraplegia | 2 (2.2%) | 3 (2.5%) | 0.868 | 0 | 2 (3.4%) | 0.157 |
| Intracranial haemorrhage | 1 (1.1%) | 0 | 0.436 | 0 | 0 | – |
| Postoperative therapeutic CSFD | 0 | 3 (2.5%) | 0.259 | 0 | 1 (1.7%) | 0.315 |
| . | Overall . | Matched . | ||||
|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | CSFD (59) . | Non-CSFD (59) . | P-value . |
| Intraoperative findings | ||||||
| Procedure time, min | 111 (91-153) | 110 (93-148) | 0.504 | 109 (88-146) | 120 (99-159) | 0.197 |
| Intraoperative blood loss, ml | 170 (70-460) | 50 (10-175) | 0.012 | 170 (50-420) | 100 (10-325) | 0.139 |
| Postoperative complications | ||||||
| Stroke | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Pneumonia | 0 | 5 (4.1%) | 0.070 | 0 | 4 (6.8%) | 0.042 |
| Continuous haemodiafiltration | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Gastrointestinal disorders | 1 (1.1%) | 2 (1.6%) | 0.717 | 1 (1.7%) | 1 (1.7%) | 1.000 |
| Access route injury | 3 (3.4%) | 3 (2.5%) | 0.749 | 3 (5.1%) | 3 (5.1%) | 1.000 |
| Wound problems | 2 (2.2%) | 1 (0.8%) | 0.418 | 0 | 0 | – |
| Infectious diseases | 1 (1.1%) | 1 (0.8%) | 0.855 | 1 (1.7%) | 1 (1.8%) | 1.000 |
| CSFD-related findings | ||||||
| SCI | 8 (9.0%) | 6 (4.9%) | 0.403 | 3 (5.1%) | 4 (7.3%) | 0.697 |
| Transient paraparesis | 6 (6.7%) | 3 (2.5%) | 0.182 | 3 (5.1%) | 2 (3.4%) | 0.648 |
| Permanent paraplegia | 2 (2.2%) | 3 (2.5%) | 0.868 | 0 | 2 (3.4%) | 0.157 |
| Intracranial haemorrhage | 1 (1.1%) | 0 | 0.436 | 0 | 0 | – |
| Postoperative therapeutic CSFD | 0 | 3 (2.5%) | 0.259 | 0 | 1 (1.7%) | 0.315 |
CSFD: cerebrospinal fluid drainage; SCI: spinal cord ischemia.
Comparison of intra- and postoperative findings and complications (entire and matched cohorts)
| . | Overall . | Matched . | ||||
|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | CSFD (59) . | Non-CSFD (59) . | P-value . |
| Intraoperative findings | ||||||
| Procedure time, min | 111 (91-153) | 110 (93-148) | 0.504 | 109 (88-146) | 120 (99-159) | 0.197 |
| Intraoperative blood loss, ml | 170 (70-460) | 50 (10-175) | 0.012 | 170 (50-420) | 100 (10-325) | 0.139 |
| Postoperative complications | ||||||
| Stroke | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Pneumonia | 0 | 5 (4.1%) | 0.070 | 0 | 4 (6.8%) | 0.042 |
| Continuous haemodiafiltration | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Gastrointestinal disorders | 1 (1.1%) | 2 (1.6%) | 0.717 | 1 (1.7%) | 1 (1.7%) | 1.000 |
| Access route injury | 3 (3.4%) | 3 (2.5%) | 0.749 | 3 (5.1%) | 3 (5.1%) | 1.000 |
| Wound problems | 2 (2.2%) | 1 (0.8%) | 0.418 | 0 | 0 | – |
| Infectious diseases | 1 (1.1%) | 1 (0.8%) | 0.855 | 1 (1.7%) | 1 (1.8%) | 1.000 |
| CSFD-related findings | ||||||
| SCI | 8 (9.0%) | 6 (4.9%) | 0.403 | 3 (5.1%) | 4 (7.3%) | 0.697 |
| Transient paraparesis | 6 (6.7%) | 3 (2.5%) | 0.182 | 3 (5.1%) | 2 (3.4%) | 0.648 |
| Permanent paraplegia | 2 (2.2%) | 3 (2.5%) | 0.868 | 0 | 2 (3.4%) | 0.157 |
| Intracranial haemorrhage | 1 (1.1%) | 0 | 0.436 | 0 | 0 | – |
| Postoperative therapeutic CSFD | 0 | 3 (2.5%) | 0.259 | 0 | 1 (1.7%) | 0.315 |
| . | Overall . | Matched . | ||||
|---|---|---|---|---|---|---|
| Variable . | CSFD (89) . | Non-CSFD (115) . | P-value . | CSFD (59) . | Non-CSFD (59) . | P-value . |
| Intraoperative findings | ||||||
| Procedure time, min | 111 (91-153) | 110 (93-148) | 0.504 | 109 (88-146) | 120 (99-159) | 0.197 |
| Intraoperative blood loss, ml | 170 (70-460) | 50 (10-175) | 0.012 | 170 (50-420) | 100 (10-325) | 0.139 |
| Postoperative complications | ||||||
| Stroke | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Pneumonia | 0 | 5 (4.1%) | 0.070 | 0 | 4 (6.8%) | 0.042 |
| Continuous haemodiafiltration | 0 | 1 (0.8%) | 0.898 | 0 | 1 (1.7%) | 0.315 |
| Gastrointestinal disorders | 1 (1.1%) | 2 (1.6%) | 0.717 | 1 (1.7%) | 1 (1.7%) | 1.000 |
| Access route injury | 3 (3.4%) | 3 (2.5%) | 0.749 | 3 (5.1%) | 3 (5.1%) | 1.000 |
| Wound problems | 2 (2.2%) | 1 (0.8%) | 0.418 | 0 | 0 | – |
| Infectious diseases | 1 (1.1%) | 1 (0.8%) | 0.855 | 1 (1.7%) | 1 (1.8%) | 1.000 |
| CSFD-related findings | ||||||
| SCI | 8 (9.0%) | 6 (4.9%) | 0.403 | 3 (5.1%) | 4 (7.3%) | 0.697 |
| Transient paraparesis | 6 (6.7%) | 3 (2.5%) | 0.182 | 3 (5.1%) | 2 (3.4%) | 0.648 |
| Permanent paraplegia | 2 (2.2%) | 3 (2.5%) | 0.868 | 0 | 2 (3.4%) | 0.157 |
| Intracranial haemorrhage | 1 (1.1%) | 0 | 0.436 | 0 | 0 | – |
| Postoperative therapeutic CSFD | 0 | 3 (2.5%) | 0.259 | 0 | 1 (1.7%) | 0.315 |
CSFD: cerebrospinal fluid drainage; SCI: spinal cord ischemia.
This PDF is available to Subscribers Only
View Article Abstract & Purchase OptionsFor full access to this pdf, sign in to an existing account, or purchase an annual subscription.
